| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |